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Methods and Materials

Patient Selection
Twenty two patients presenting head and neck tumors, were considered for VMAT. Table 1 shows the descriptive data of the patients. It includes 19 males and 3 females with a median age of 62 years (range 40 -76 years). This study was approved by the ethics committee and informed consent for treatment was obtained from all the patients. To have unbiased comparison of VMAT and IMRT plan quality, patients who were treated with VMAT were also planned IMRT. Each patient served as his own control for the dosimetric and technical parameters comparison.
Volume Definition and Treatment Planning
All patients were simulated in supine position using a thermoplastic mask and shoulder retraction. A planning CT scan with contrast was performed with slice thickness of 3mm. A planning MRI scan was performed in the same position. The two images were transferred to the Eclipse planning systems (10.0.39) and were fused using rigid registration algorithm for delineation of target and organs at risk (OARs). Gross Tumour Volume (GTV) was defined as the gross extent of tumour shown by imaging, including all involved (positive) lymph nodes. MRI and in few cases FDG-PET were used in the delineation of GTV. On the basis of the primary tumour size and involved nodes, the CTV 70 was defined as GTV (guided by clinical criteria and FDGPET imaging whenever available) plus a margin for microscopic spread, and the CTV 54 included precautionarily uninvolved nodes defined as CTV. Planning Target Volume (PTV) was generated by expanding the CTV by 5 mm in all directions [ICRU 50 and 62] . Organs at risks (OARs) such as Spinal Cord, left and right Parotids Larynx and uninvolved Oral Cavity were contoured. In addition, the healthy tissue was defined as the patient's volume included in the CT data set and excluded all PTV volumes. Dose was prescribed to mean PTV dose for the high dose level as simultaneous integrated boost (SIB) with two dose levels of 54 Gy and 70 Gy in 35 fractions (1.54 and 2.0 Gy/fraction, respectively). All patients were treated with 6 MV X-ray beams delivered by varian UNIQUE performance equipped with a millennium multi leaf collimator (mlc) with 120 leaves (spatial resolution of 5 mm at isocentre for the central 20 cm and of 10 mm in the outer 2 × 10 cm, leaf transmission of 1.86%). For each patient two plans were prepared with Similar Plan objectives, one using large fields sliding window IMRT and another using Rapid Arc. The sliding window IMRT plan consisted on 7 -9 gantry angles. For most of the patients gantry angle was fixed at 0˚, 40˚, 80˚, 120˚, 160˚, 200˚, 240˚, 280˚ and 320˚. Beam angles were selected in order to avoid opposite entrance. All beams were coplanar and collimator angle set to 20˚ to reduce the tongue and groove effect. Plan optimization was performed on the basis of dose-volume constraints with fixed 400 MU/min. The VMAT consisted on two arcs (clockwise and counter clockwise direction) of 358˚ each and collimator angles set to 30˚ and 330˚ were used. Both arcs were coplanar. VMAT plan optimization with PRO-III implemented in Eclipse planning system was performed on the basis of appropriate dose volume constraints which were used for IMRT optimization. A maximum dose rate of 600 MU/min was applied. Dose of both the plans were calculated using anisotropic analytical algorithm (AAA) with calculating grid size of 2.5 mm.
For both Rapid Arc and LF-IMRT plans, dose volume objectives for PTVs were: At least 95% of the PTV coverage is 95% of the prescribed dose and dose maximum not to exceed 107% of the prescribed dose. Concerning OARs, the constraints were following: Spinal cord: D 1% < 46 Gy; Parotids (left and right analysed separately): D mean < 26 Gy, V 30Gy < 45%; larynx: D mean < 45 Gy and uninvolved oral cavity: D mean < 30 Gy. For healthy tissue (defined as the entire body volume included in the CT scan subtracted all PTVs), various thresholds like V 5Gy , V 30Gy and mean dose were reduced to as low as possible.
Evaluation Parameter
Evaluation of plans was based on dose volume histogram (DVH) analysis. For each PTV, the values of D 98% and D 2% (Dose received by the 98% and 2% of the target volume) were defined as metrics for minimum and maximum doses respectively. Also D 80% , D 50% and V 107% were reported. The homogeneity of the dose distribution was measured by D 5% − D 95% and expressed as HI = (D 5% − D 95% )/D 50% . The lower HI value, the better dose homogeneity. Ideal value is equal to zero. Conformity of Dose was scored as conformity index (CI 95% ) which was computed for each plan using the equation CI 95% = (TV PI /TV) × (TV PI /PI). Where TV PI represents the target volume with in the 95% of prescribed iso-dose volume, TV is the volume of PTV and PI is the volume of 95% of prescribed iso-dose volume [8] . A perfect plan would have a TV PI = TV = PI then, CI 95% = 1.
In OARs, the mean dose, the maximum dose (D 1% ) and appropriate values of V xGy (Volume receiving at least × Gy) were analysed. For healthy tissue, the integral dose of the absorbed dose extended to over all voxels excluding the volume of all targets. It was computed for each plan using the equation, Integral Dose = i=1 Σ m V i D i . Where V i and D i are volume and dose of voxel "i".
Technical features of treatment have been reported in terms of main delivery parameters: total monitor unit (MU) per fraction and treatment time (defined as Beam on time plus machine programming time and excluding patient positioning and imaging procedures). Results of pre treatment plan quality assurance were reported as gamma agreement Index(GAI) (i.e., percentage of modulated field area passing the γ-index criteria of Low et al. [9] , with thresholds on dose difference set to ∆D=3% of the significant maximum dose and distance to agreement set to DTA = 3 mm). Measurements and analysis were performed by means of the GlAaS methodology described in [10] [11] based on absorbed dose to water derived from EPID measurements. Pre treatment dosimetry was considered satisfactory if gamma agreement index (GAI) ≥ 95%.
Statistical analysis was performed using SPSS (version 16.0.0, SPSS, Chicago, USA). Independent student "t" test was used to compare both treatment techniques. A p value < 0.05 was considered statistically significant. Figure 1 shows the axial, sagittal and coronal view of dose distribution and refers to one patient. Figure 2 and Figure 3 show the comparison DVH for PTVs and OARs respectively. Table 2 and Table 3 give an overview of the numerical results from average DVH analysis on PTVs and OARs respectively and report mean values ± standard deviation (SD) and "p" values to assess the relative inter-patient variability. Table 4 gives details of the technical characteristics.
Results
As it is now, it is difficult to understand, the target volume was to receive at least 95% of the prescribed dose, but has received higher than 96% of the target volumes in both techniques. Mean dose of PTV 70Gy was achieved better (70.56 ± 1.10 Gy) with Rapid Arc without increasing dose maximum than (71.66 ± 1.08 Gy) with IMRT. Rapid Arc plans achieved higher dose conformity index (CI 95% ) (0.906 ± 0.029, closer to a value of 1) than with IMRT (0.868 ± 0.067) and the p = 0.021 shows significant difference. The Homogeneity index (HI 95% ) statistically does not differ in both techniques but, mean homogeneity index (HI 95% ) shows higher with Rapid Arc (0.089 ± 0.020) than with IMRT (0.097 ± 0.03). For PTV 54Gy the coverage was adequate in both techniques. However, homogeneity index was achieved better with Rapid Arc (0.097 ± 0.3) than with IMRT (0.25 ± 0.10).
Spinal Cord dose was below the tolerance limit for both techniques. However, D 1% of Spinal cord with Rapid Arc was 37.7 ± 4.67 Gy and with IMRT was 40.68 ± 7.14 Gy. Both left parotid and right parotid received with VMAT are 21.26 ± 8.5 Gy and 22.37 ± 7.44 Gy which are lesser than with IMRT 22.78 ± 11.2 Gy and 24.1 ± 7.96 Gy respectively. Average mean dose Larynx was (37.49 ± 2.7 Gy) with Rapid Arc than with IMRT (41.7 ± 4.2 Gy). Likewise, the average mean dose of uninvolved oral cavity also was lesser with rapid Arc. Concerning Healthy Tissue, Lower dose irradiation volume V 5Gy was little higher with Rapid Arc (37.90% ± 9.33%) than with IMRT (37% ± 9.67%). However, higher dose irradiation volume V 30Gy was lesser with Rapid Arc (10.07% ± 3.93%) than with IMRT (13.1% ± 5.2% •Gy). The average monitor unit(MU) needed to deliver the dose of 200 cGy/fraction was 523 ± 116 MU for Rapid Arc and 2127 ± 570 for the 9 field IMRT plan (p < 0.00001). The total Beam On time (Excluding patient setup and Image verification) was 2.14 ± 0.43 min for Rapid Arc and 9.16 ± 2.5 min for IMRT (p < 0.00001). Pre-treatment quality assurance of all plans resulted in average gamma agreement index (GAI). The GAI scored with 3 mm and 3% constraints was 97.84% ± 1.1% with Rapid Arc plans and 95.23% ± 1.7% with IMRT plans. The acceptable GAI threshold was set to 95% as a reference in the hospital.
Discussion
Different planning studies comparing the volumetric modulated arc therapy with conventional IMRT in different sites have been published [12] - [15] . The study published by Richard et al. [16] . Shows VMAT had shorter Beam-On time and more homogeneous dose distribution compared with 7 field, step and shoot IMRT for prostate cancer. In another study published by Mahantshetty, swamidas Jamema et al. [17] shows that Rapid Arc allows the generation of adequate dose distribution with high target homogeneity, sufficient sparing of organs at risk and minimization of patient moment compared to IMRT. The mean dose of PTV 70Gy received adequately with both techniques, however, Rapid Arc mean dose was differ significantly (p = 0.011) than IMRT. Conformity Index (CI 95% ) (p = 0.021), dose of D 80% (p = 0.002) and D 50% (p = 0.003) were significantly higher with Rapid Arc than IMRT, while the V 107% (p = 0.288) and homogeneity Index (HI 95% ) (p = 0.28) did not differ significantly with IMRT. Therefore, the dose fall-off with Rapid Arc is higher than IMRT. The advantage of steep dose fall-off with Rapid Arc technique achieved higher Homogeneity for proximity target with low dose prescription PTV 54Gy significantly (p = 0.0001) than IMRT.
When using IMRT for irradiation of oropharyangeal cancer salivary functions was less impaired, but the majority of the patients still suffered from some degree of xerostomia [18] - [20] . Braam et al. showed--that the normal tissue complication probability (NTCP) at several time points after radiation therapy was less than 20% only if the mean dose to the parotid glands was lower than 25 Gy [21] . The average mean dose of both left parotid and right parotid received with VMAT were lesser than with IMRT. However, significantly not differ. V 30Gy of parotid was also lesser with Rapid Arc than IMRT, It ensures that irradiation of higher dose volume is reduced.
Kirk Patrice et al. [22] . reported that the incidence rate for radiation myelitis is 0.2, 6% and 50% the total dose for 50 Gy, 60 Gy, and 69 Gy respectively, when administrated at the conventional fraction of 2 Gy/day. In addition, according to the Radiation Oncology Group of European Organisation for Research and Treatment of Cancer, the maximal radiation dose that should be applied to the Spinal Cord is 45 Gy, and it should not exceed 40 Gy if oxaliplatin Chemotherapy is administered as well [23] . In this study the Spinal Cord dose did not reach the tolerance level in both techniques. Hovever, Sparing of spinal cord was significantly higher with Rapid Arc (p = 0.047) than IMRT. Betzel et al. [24] reported that RapidArc deliveries were found to be more tolerant to variations in dose rate, gantry position, and MLC leaf position than fixed-field IMRT with dynamic SW delivery. Dose rate variations during RapidArc must be large to affect dose distributions significantly; dynamic IMRT is inherently not susceptible to such variations. Clinically acceptable treatments may be delivered accurately using Rapid Arc despite large fluctuations in dose rate and gantry position [24] . The dose to targets was delivered with more degrees of the freedom in Rapid Arc technique allowed to spare significantly the larynx (p = 0.002) and uninvolved oral cavity (p = 0.004) which are located in between the targets.
Concerning Healthy Tissue, the irradiation of higher volume by lower dose (p = 0.828) was not differ significantly. However, higher dose irradiation volume V 30Gy was lesser with Rapid Arc significantly (p = 0.037). Computed integral dose of prescribed dose irradiation at non-tumor volume with Rapid Arc was lesser than with IMRT, there was no significant difference (p = 0.828). Jia.et al. found that the scatter dose predominates in the peripheral dose in VMAT, while the leakage dose predominates in IMRT, Moreover, leakage dose contribution to the peripheral dose becomes quite large and the peripheral dose at distant point is higher [25] . When evaluating radiation dose to healthy tissues, especially at sites remote from the treatment region, radiation leakage may represent an important factor, increasing integral dose to normal structures [26] . Specifically, two main sources of leakage from LINAC can be considered to increase the patient's Non-Tumour Integral Dose (NTID). (i) transmission of radiation through the collimator leaves and leakage through the primary collimation system. It is generally believed that leakage through the leaves of a conventional collimator might carry a significant contribution to peripheral integral dose (leakage is about 2.5% for 6 MV photon beams). (ii) leakage radiation is the dominant component and is directly related to the number of MU delivered [26] . Such a leakage radiation doses can increase the risk of secondary malignancy. In our study, the required monitor unit to deliver the prescribed dose with similar dose distribution of targets and OARs with IMRT was three times more than Rapid Arc (p < 0.00001). The impact of irradiation of healthy tissues at low doses with the VMAT technique is remains unre-solved. Longer treatment delivery times increase the chance of patient displacement during IMRT [27] - [29] . The treatment time for delivering the Rapid Arc plans was significantly lesser (p < 0.00001) than IMRT. This difference may have significantly impact on IMRT outcome, especially for tumors with a low α/β ratio and a short repair half time [30] .
It is important to understand that whether treating with Rapid Arc or IMRT, pre treatment quality assurance is vital to safe and effective patient care. The reliability and efficacy of the Rapid Arc modality as anticipated in dosimetric investigation [31] - [33] . The results of our study was, the GAI scored with 3mm and 3% constraints was more than acceptable threshold of 95% with both techniques. Our QA passing results agree with Verbakel et al. Published report [34] . High resolution of the detector (EPID) emphasizes the difficulties of the treatment planning system in properly managing the interleaf transmission and tongue and groove effect to notify the failing points in the delivery.
Conclusion
The Rapid Arc (VMAT) delivered the dose rapidly with lesser Monitor Unit without compromising in target dose coverage, conformity and higher sparing of OARs than IMRT. Thus, the risk of intra-fractional patient movement is reduced. The collimator transmission as scattered radiation from the Linac, Which is proportional to the number of MU and can increase potential risk of secondary cancer is now largely reduced by the Rapid Arc. These advantages can allow increase in dose/fraction and deliver in very short time a higher dose level at the same time keep maintain lesser OARs dose.
